Pulmosmart 400 Pulmicaps
bottle of 30.0 capsules.Prescription required
About this product:
| Salt Composition: | Formoterol (6mcg) + Budesonide (400mcg) |
| Manufacturer: | Alkem Laboratories Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Pulmosmart 400 Pulmicaps is a combination of two medicines in one inhaler that relieves long-term symptoms of asthma and COPD, making breathing easier. Pulmosmart 400 Pulmicaps is a combination of two medicines in one inhaler. It relieves the long-term symptoms of asthma and COPD, making breathing easier. It works by inhibiting the release of certain chemical messengers that cause inflammation (swelling) and relaxes the muscles in the airways.
Pulmosmart 400 Pulmicaps is a combination of two medicines: Formoterol and Budesonide. Formoterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widens the airways. Budesonide is a steroid. It works by stopping the release of certain chemical messengers that cause inflammation (swelling) of the airways. Together they make breathing easier.
Take this medicine in the dose and duration as advised by your doctor.
- It contains two medicines in one inhaler for control of long term asthma and COPD symptoms.
- It does not relieve sudden symptoms. Always use a rescue inhaler to treat sudden symptoms.
- Tell your doctor immediately if your breathing problem worsens or if rescue inhaler does not relieve symptoms.
- Do not discontinue unless advised by your doctor.
- Rinse your mouth with water after each use to prevent infections in the mouth and throat.
- Carry your rescue inhaler wherever you go.
- No common side effects listed.
Alcohol
It is unsafe to consume alcohol with Pulmosmart 400 Pulmicaps.
Breastfeed
Pulmosmart 400 Pulmicaps is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy
Pulmosmart 400 Pulmicaps is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
